drugset / Trial / NCT00561067
Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP)
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the tolerability and efficacy of erythropoietin (EPO) treatment in spinal shock in comparison with the methylprednisolone treatment (MP).
Timeline
- Start
- 2008-04
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylprednisolone | Other / unclassified | 5.4 mg/kg | Intravenous |
| Subject | epoetin alfa | Protein / enzyme biologic | 500 iu/kg | Intravenous |